|
Volumn 48, Issue 11, 2000, Pages 1521-1524
|
Guidelines abstracted from consensus recommendations for the management of chronic heart failure
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
CARVEDILOL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
FELODIPINE;
FOSINOPRIL;
HYDRALAZINE;
INOTROPIC AGENT;
ISOSORBIDE DINITRATE;
LISINOPRIL;
LOOP DIURETIC AGENT;
METOLAZONE;
QUINAPRIL;
RAMIPRIL;
THIAZIDE DIURETIC AGENT;
WARFARIN;
COST BENEFIT ANALYSIS;
DOPPLER ECHOCARDIOGRAPHY;
DRUG SAFETY;
FLUID BALANCE;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
LIFESTYLE;
MORBIDITY;
MORTALITY;
PRACTICE GUIDELINE;
RADIOISOTOPE VENTRICULOGRAPHY;
SHORT SURVEY;
THORAX RADIOGRAPHY;
|
EID: 0033781166
PISSN: 00028614
EISSN: None
Source Type: Journal
DOI: 10.1111/jgs.2000.48.11.1521 Document Type: Short Survey |
Times cited : (4)
|
References (0)
|